YELENA GIMELSHTEYN: Open Payments
NPI 1336376292 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 20 payments from 6 companies in 2025. Trend: 2023 $93 · 2024 $264 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $102 |
| E.R. Squibb & Sons, L.L.C. | 6 | $101 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, COBENFY, UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
